We're sorry but this app doesn't work properly without JavaScript enabled. Please enable it to continue. Rights Issue: APS Bank p.l.c. - MeDirect

Picture your Future. Save for it by earning 1.5% on a 1-year Term Deposit Account! Learn more.

Rights Issue: APS Bank p.l.c.

APS Bank plc has announced a Rights Issue to raise approximately €45 million in new equity. The Rights Issue will offer existing shareholders the opportunity to subscribe for new ordinary shares at a ratio of 3 new shares for every 11 shares held, at a price of €0.44 per share. The Record Date for determining eligibility is Monday, 6 October 2025 (with the last trading date being Thursday, 2 October 2025).

Key Highlights

  • APS Bank plc intends to raise approximately €45 million in fresh equity through a Rights Issue of new ordinary shares.
  • The Rights Issue is part of APS Bank’s strategy to strengthen its capital base, support future growth, and comply with regulatory capital requirements.
  • Any new shares not taken up by existing shareholders will be offered via an Intermediaries’ Offer to other potential investors.

Why APS Bank Is Launching the Rights Issue

In recent years, APS Bank has pursued growth both organically and through targeted acquisitions, while also working to reinforce its capital structure. The Rights Issue is designed to support expanded lending capacity, increased investment in technology, and broader market reach.

Additionally, the Bank’s two qualifying shareholders, AROM Holdings Ltd (Archdiocese of Malta) and Diocese of Gozo, currently hold approximately 54.67% and 12.52%, respectively. Under conversion and dilution plans, these shareholders are expected not to fully subscribe to their rights, which may further reduce their proportionate stakes in APS Bank.

Application Process:

  • For Customers Holding Shares Under Nominee:
    • You will receive a Secure Message from us with detailed instructions on how to apply for the Rights Issue.
  • For Customers with Direct Holdings:
    • You will receive the application form by post, along with instructions on how to proceed.

Important Dates:

  • Record Date: Monday, 6 October 2025
  • Last Trading Date: Thursday, 2 October 2025
  • Offer Price: €0.44 per new ordinary share

Full details about this issue are set out in the Base Prospectus dated 22 October 2025 on the APS website accessible from https://www.apsbank.com.mt/rights-issue/.

If you are interested in applying, please send us a Secure Mail or contact your Relationship Manager.

For further information, please call us on (+356) 2557 4400 or send an email to customerservice@medirect.com.mt.


The information set forth in this article is only for informative purposes and should not be construed as an offer to sell or solicitation of an offer to subscribe for or purchase any investment. The information provided is subject to change without notice and does not constitute investment advice or any guarantee of returns. Please consider the terms and conditions governing the relevant investment prior to making any investment decision. Investors should note that at worst they may lose all of their invested principal in the event of default, insolvency and/or bankruptcy of the relevant issue. The financial instruments discussed may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

The financial instruments discussed are intended for retail clients, however, may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

MeDirect Bank (Malta) plc has based this document on information obtained from sources it believes to be reliable but which have not been independently verified. MeDirect Bank (Malta) plc does not therefore provide any guarantees, representations or warranties. The value of any investment or income may go up as well as down and past performance is no guarantee of any future performance. When an investment is denominated in a currency other than your local or reporting currency, changes in exchange rates may have an adverse effect on your investment.

MeDirect Bank (Malta) plc, company registration number C34125, is licensed by the Malta Financial Services Authority under the Banking Act (Cap. 371) and the Investment Services Act (Cap. 370). This material shall not be reproduced in any way, whether in whole or in part. Any unauthorised disclosure, use or dissemination, either in whole or in part, of the material contained within is strictly prohibited.

Join MeDirect today to access the tools you need to put your money to work on your own terms.

Latest news articles

Epic Investment Partners Weekly Article
All News

Epic Investment Partners Views: The Week Ahead

Markets face a packed week of key US data and global PMIs amid heightened geopolitical tensions, sticky inflation and shifting rate-cut expectations, while China pivots toward structural demand support and AI-driven economic strategy.

New Bond Issue - IZI Finance
All News

New Bond Issue: IZI Finance p.l.c.

MeDirect Bank (Malta) plc is now accepting applications for the €30,000,000 IZI Finance p.l.c. 5.5% Unsecured Bonds redeemable in 2036.

Experience better Banking

The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. 


Sign up and open your account for free, within minutes.

MeDirect_Multi-Devices-cards

You are leaving medirect.com.mt

Please be aware that the external site policies, or those of another MeDirect website, may differ from this website’s terms and conditions and privacy policy. The next website will open in a new browser window or tab.

 

Note: MeDirect is not responsible for any content on third party sites, nor does a link suggest endorsement of those sites and/or their content.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.